BIOHEART-B (02185) released its interim results, reporting a pre-tax loss of 33.375 million yuan, an increase of 21.72% year-on-year.
Baixin An-B (02185) announced its interim results for the six months ending June 30, 2026, reporting revenue of 14.377 million yuan, a decrease of 31.09% year-on-year; a pre-tax loss of 33.375 million yuan, an increase of 21.72% year-on-year; and a loss per share of 0.13 yuan.
BIOHEART-B (02185) announced its interim results for the six months ended June 30, 2026, reporting revenue of 14.377 million yuan, a year-on-year decrease of 31.09%; a pre-tax loss of 33.375 million yuan, an increase of 21.72% year-on-year; and a loss per share of 0.13 yuan.
For the six months ended June 30, 2026, the company recognized revenue of 14.4 million yuan (for the six months ended June 30, 2025: 20.9 million yuan), which includes sales of goods totaling 12.5 million yuan and 1.9 million yuan from collaborative income.
Related Articles
JANCO HOLDINGS (08035) announced its interim results, with profit attributable to shareholders of HK$3.252 million, turning from loss to profit year-on-year.
ZENGAME (02660) announced its interim results, with an adjusted net profit of 175 million yuan, a year-on-year decrease of 14.5%.
YANCHANG PETRO (00346): Hu Yujie has been appointed as the chairman of the board, executive director, and authorized representative.
JANCO HOLDINGS (08035) announced its interim results, with profit attributable to shareholders of HK$3.252 million, turning from loss to profit year-on-year.
ZENGAME (02660) announced its interim results, with an adjusted net profit of 175 million yuan, a year-on-year decrease of 14.5%.
YANCHANG PETRO (00346): Hu Yujie has been appointed as the chairman of the board, executive director, and authorized representative.
RECOMMEND
